GGrantIndex
Sort

91,797 grants matching obesity

Carbohydrate: Amount and Type Affecting Risk for CVD and Diabetes

$2,362,602
Frank M Sacks · Brigham And Women'S Hospital · R01 · FY2008 · HL

Triglycerides, Diabetes and Cardiovascular Disease

$2,360,354
Karin E. Bornfeldt · University Of Washington · P01 · FY2022 · HL

Individual Differences in Obstructive Sleep Apnea

$2,359,665
Allan Ian Pack · University Of Pennsylvania · P01 · FY2017 · HL

Long-term impact of random assignment to intensive lifestyle intervention on Alzheimers disease and related dementias: The Action for Health in Diabetes ADRD Study (Look AHEAD-MIND)

$2,359,595
Mark Andrew Espeland · Wake Forest University Health Sciences · R01 · FY2018 · AG

Hearing Impairment in Long-Term Type 1 Diabetes

$2,357,551
Rose A Gubitosi-Klug · Case Western Reserve University · DP3 · FY2013 · DK

Immunophenotyping of Human Hypertension Using Single Cell Multiplex Mass Cytometry to Identify Novel Therapeutic Targets

$2,355,000
Meenakshi Swaminathan Madhur · Vanderbilt University Medical Center · DP2 · FY2016 · HL

Harnessing Mindset in 21st Century Healthcare

$2,355,000
Alia Crum · Stanford University · DP2 · FY2016 · AT

Reconstructing Primary Cilia

$2,355,000
Rajat Rohatgi · Stanford University · DP2 · FY2012 · GM

COBRE in Nutrition and Women's Health

$2,354,626
Michelle Kay McGuire · University Of Idaho · P20 · FY2024 · GM

Epidemiologic studies of maternal and early life metabolic risk

$2,354,322
Madhumita Sinha · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK

The Fragile Families Cardiovascular Health Follow Up Study

$2,354,049
Daniel A Notterman · Princeton University · R01 · FY2020 · HL

HYPERGLYCEMIA AND ADVERSE PREGNANCY OUTCOME

$2,353,615
Northwestern University · R01 · FY2001 · HD

CONTRACEPTIVE CLINICAL TRIALS NETWORK, CLINICAL EVALUATION OF LARC METHODS TO DETERMINE COMPARATIVE EFFECTIVENESS, ACCEPTABILITY, AND SAFETY.

$2,353,361
Dart Clint · Health Decisions, Inc. · N01 · FY2021 · HD

New Molecules in Triglyceride Metabolism and Adipogenesis

$2,352,632
Stephen G Young · University Of California Los Angeles · P01 · FY2014 · HL

Vascular Consequences of Insulin Resistance and Obesity

$2,351,521
Joseph A. Vita · Boston University Medical Campus · P50 · FY2010 · HL

Molecular pathological epidemiology of colorectal cancer

$2,351,030
Ulrike Peters · Fred Hutchinson Cancer Research Center · U01 · FY2016 · CA

The VETSA Longitudinal Twin Study of Cognition and Aging (VETSA 3)

$2,350,415
William S Kremen · University Of California, San Diego · R01 · FY2015 · AG

Support services for the NIDDK Epidemiology Coordinating Committee

$2,349,467
Social And Scientific Systems, Inc. · N01 · FY2019 · HD

Clinical Centers for the Osteoarthritis Initiative

$2,348,787
University Of Pittsburgh At Pittsburgh · N01 · FY2010 · DC

Small Animal Metabolic Surgery (SAMS) Resource Core

$2,347,532
Lee Michael Kaplan · Massachusetts General Hospital · RC2 · FY2010 · DK

Center of Biomedical Research Excellence in Cardiovascular Health

$2,347,347
David G Edwards · University Of Delaware · P20 · FY2022 · GM

New Biospecimens to Enhance Research in the California Teachers Study Cohort

$2,346,598
James V Lacey · Beckman Research Institute/City Of Hope · UM1 · FY2012 · CA

STEPS TO A HEALTHIERUS: A COMMUNITY-FOCUSED ASTHMA, DIABETES, AND OBESITY

$2,346,514
Margaret M Tate · Arizona State Department Of Hlth Srvcs · U58 · FY2007 · DP

FSH - an Aging Hormone?

$2,346,376
Mone Zaidi · Icahn School Of Medicine At Mount Sinai · U19 · FY2020 · AG

MACS/WIHS Combined Cohort Study: Brooklyn Clinical Research Site (Bklyn CRS)

$2,345,000
Deborah R. Gustafson · Suny Downstate Medical Center · U01 · FY2019 · HL